Reduction in Baseline CD4 Count Testing Following Human Immunodeficiency Virus "Treat All" Adoption in Uganda.
Nasuuna, Esther;
Tenforde, Mark W;
Muganzi, Alex;
Jarvis, Joseph N;
Manabe, Yukari C;
Kigozi, Joanita;
(2020)
Reduction in Baseline CD4 Count Testing Following Human Immunodeficiency Virus "Treat All" Adoption in Uganda.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71 (9).
pp. 2497-2499.
ISSN 1058-4838
DOI: https://doi.org/10.1093/cid/ciaa261
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
Baseline CD4 testing rates declined from 73% to 21% between 2013 and 2018 with adoption of "Treat All" in Uganda. Advanced human immunodeficiency virus (HIV) disease (CD4 count < 200 cells/µL) remained common (24% of those tested in 2018, 83% of whom had World Health Organization stage I/II disease). Despite frequent presentation with advanced HIV disease, CD4 testing has declined dramatically.